0
New Jersey regulators approve $8.5B drugmaker merger
NEW JERSEY, N.J. (Reuters) – New Jersey’s regulators approved a $8,542 million merger between two New Jersey-based drugmakers on Wednesday
0
What to know about Tesla and SpaceX’s plans for the skies
Tesla and its SpaceX-backed rival SpaceX are building a fleet of new airliners that could rival the world’s biggest private aircraft manufacture